Vertex Pharma (VRTX) Approves Additional $4B Buyback Program
Tweet Send to a Friend
Vertex Pharma (NASDAQ: VRTX) disclosed:
The Board of Directors of Vertex Pharmaceuticals Incorporated (the “Company”) has authorized an additional program ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The Board of Directors of Vertex Pharmaceuticals Incorporated (the “Company”) has authorized an additional program ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


